Empowering Futures: Restoring T-Cell Responses in Children Living With HIV

Area of Science:

• Immunology
• Pediatric infectious diseases
• HIV/AIDS research

Background:

• Antiretroviral therapy (ART) is standard for managing HIV in children.
• Immune reconstitution after ART can be incomplete, particularly for specific T cell responses.
• Mycobacteria-specific T cell function is critical for controlling infections like tuberculosis.

Purpose of the Study:

• To evaluate the recovery of mycobacteria-specific T cell responses in children with HIV after six months of ART.
• To identify persistent immune deficits despite ART initiation.
• To highlight the implications for tuberculosis susceptibility in this population.

Main Methods:

• Analysis of mycobacteria-specific T cell responses (e.g., cytokine production, proliferation).
• Assessment of T cell subsets, including Th1 CD4 T cells.
• Longitudinal monitoring of immune markers in pediatric patients undergoing ART.

Main Results:

• Children with HIV exhibited persistent deficiencies in mycobacteria-specific T cell responses six months post-ART.
• Elevated levels of Th1 CD4 T cells were observed, but did not fully restore mycobacteria-specific immunity.
• Immune recovery remained suboptimal, indicating potential vulnerability.

Conclusions:

• Six months of ART may be insufficient for complete restoration of mycobacteria-specific T cell immunity in children with HIV.
• Persistent immune deficits underscore the need for targeted interventions to mitigate tuberculosis risk.
• Continuous health empowerment strategies are essential for managing long-term health in immunocompromised children.